Profile: ChromaXome Corporation focuses on genetic engineering technology to develop large numbers of drugs and derivatives. We develop drugs from marine micro-organisms. We offer initial in-house drug discovery efforts on anti-infectives. We specialize in splicing DNA sequences from unique marine microorganisms into common industrial micro-organisms such as E.coli or streptomyces in order to express large numbers of novel chemicals for screening.